- STAT+: Alnylam to partner with Inceptive Nucleics for AI foundation models for RNAi therapeuticsAlnylam announced a three-year deal with Inceptive, worth up to $2 billion, with $30 million up front in cash and equity in the startup.STAT · 1mo ago↗ source
- STAT+: HaloMD faces lawsuit alleging No Surprises Act middleman used ‘sham letter,’ misleading dataHighmark Health is the fourth insurer to sue HaloMD, seeking to overturn arbitration wins.STAT · 1mo ago↗ source
- Legend surges on early data for ‘in vivo’ lymphoma cell therapy<figure><div><img src="https://imgproxy.divecdn.com/WrykHCObgQORJy6_Nsx19TUHTg8V8DEoa5UN1HcFlZc/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMTcxODMyMDY3LmpwZ…